30.09.2010 • News

2nd Annual Product Portfolio Management Benchmark Study

Appleseed Partners, in partnership with OpenSky Research, and sponsored by Planview are conducting the second annual Product Portfolio Management Benchmark Study designed to gain a better understanding of the dynamic environment product development professionals are working in and their approaches to managing the innovation to commercialization process.

The first study was completed in June, 2009 and this year promises more participants and more in-depth research. Last year, with more than 400 product development professionals participating, we had some interesting takeaways including:

• More than half of respondents had too many projects for their resources and resource capacity planning issues.
• 57% said that their greatest risk was missing critical market windows.
• Only 11% of companies constantly monitor and stop underperforming projects.
• Nearly 50% described their companies as "risk-averse" and less likely to make bets on new product innovation.
• Most respondents had a strong dependence on using spreadsheets, and basic office an project tools to manage sophisticated product pipelines.

This year's survey is only open through Wednesday, 29 September, 2010. You are invited to participate and in appreciation for your time and input, you'll receive a complimentary copy of the full report in November, 2010, as well as the 2009 report. You'll also be entered to win a 32GB Apple iPad.

Click here to participate.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.